Email Contact Phone Company Visit Website

Location Office

Kungsgatan 36
Stockholm
SE

NASDAQ OMX New York Head Office

One Liberty Plaza
New York
NY
US

NASDAQ OMX Stockholm Office

Tullvaktsvägen 15
Stockholm
SE

NASDAQ OMX Rockville Office

805 King Farm Boulevard 1st and 2nd floor
Rockville
MD
US

NASDAQ OMX London Office

Woolgate Exchange, 25 Basinghall Street, City of London
London
GB

NASDAQ OMX New York Office

Marketsite 4 Times Square
New York
NY
US

NASDAQ OMX Hong Kong Office

Room 1207-8, 12/F Man Yee Building 68 Des Voeux Road Central Hong Kong
Hong Kong
HK

NASDAQ OMX Singapore Office

20 Collyer Quay, #17-01
Singapore
SG

NASDAQ OMX Chicago Office

One North Wacker Drive Suite 3600
Chicago
IL
US

NASDAQ OMX Belgium Office

Avenue de Cortenbergh 116
Brussels
BE

NASDAQ OMX Dubai Office

Dubai World Trade Centre Sheikh Zayed Road
Dubai
AE

NASDAQ OMX Tokyo Office

1F, Kojimachi Square Building Nibancho, 3 Chiyoda-ku, Tokyo
Tokyo
JP

NASDAQ OMX Boston Office

100 Franklin St
Boston
MA
US

Location Office

Level 17-19, 110 Bishopsgate
London
GB

Telephone

212 231 5018

Contact

Todd A Swearingen
[email protected]
Back to all NASDAQ OMX announcements

NASDAQ OMX welcomes Brighter to First North

NASDAQ OMX (NASDAQ: NDAQ) announces that the trading in Brighter AB (BRIG) shares commenced today on First North at NASDAQ OMX Stockholm. Brighter was previously listed at Aktietorget. Brighter belongs to the Healthcare sector and is the third new company to be admitted to trading on First North’s Nordic markets (Stockholm, Helsinki, Copenhagen and Iceland) in 2014.

Brighter develops and commercializes innovative solutions for diabetes self-care. Brighter One™ is a patented solution from Brighter which gives the company exclusive rights to produce the world's first handheld device that reduces the number of items a diabetic needs to carry along from five to one.

“Today we start a new phase where we, after having brought in new strategically important investors into the shareholder base and raised over SEK 35 million from new and existing shareholders, make our share accessible to a larger group of investors by moving to First North,” says Brighter's CEO Truls Sjöstedt. “We will now put all our time and efforts into our solution to provide an easier everyday life for millions of diabetics all over the world.”

“We are excited to welcome Brighter to First North and to our healthcare sector,” said Adam Kostyal, Senior Vice President at NASDAQ OMX. “Right now we are seeing a lot of interest for the public markets among biotech and medtech companies. Brighter’s decision to move its listing to our First North market underlines this trend and we hope that more companies will follow their example.”